No abstract available
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Humans
-
Immunoconjugates* / therapeutic use
-
Lymphoma, Large B-Cell, Diffuse* / drug therapy
-
Lymphoma, Large B-Cell, Diffuse* / genetics
-
Salvage Therapy
Substances
-
Antibodies, Monoclonal
-
Immunoconjugates
-
polatuzumab vedotin